MoneyWorks4Me

Dr. Reddy’s launches generic Azacitidine for Injection in Canadian Market

03 Nov 2017 Evaluate

Dr. Reddy’s Laboratories has launched generic Azacitidine for Injection in the Canadian Market. The generic Azacitidine for injection 100 mg/vial, a bioequivalent generic version of VIDAZA (azacitidine for injection), is approved by Health Canada. VIDAZA is a trademark of Celgene.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.


Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..